The Trendlines Group receives $8 million investment
Librae Holdings Limited, a company related to Vincent Tchenguiz, invests at SGD 0.105 per share.
Vincent Tchenguiz is best known for his multibillion-pound real estate portfolio. In the past three years, he has diversified his investments with increased focus on biotechnology and planet-related technologies and built a $350 million technology VC portfolio managed by a strong tech investment team. Many of his investments are in incubators, venture funds, and several medical companies in Israel.
Trendlines’ history of developing early-stage companies, combined with its hands-on investment policy and the potential of its 53 portfolio companies, makes it an attractive investment with significant potential.
We believe in Trendlines’ business model and are convinced that this represents a great opportunity.
He also noted that “today our investments are focused on Europe, Israel, and the United States, but we have been looking at Singapore as a target for a long time, and we view Trendlines as an avenue into that important market. We believe we could provide new markets for the underlying companies and very much like the concentration in agritech and medical devices that fit on developing financial model both in health care and planet ecosystem which includes agritech/food tech and cleantech.”
We are very excited to have Librae Holdings join us as a shareholder. Their numerous life science investments in Israel and around the world make them more than a financial investor, but an investor with the ability to provide strategic value to Trendlines.
Trendlines Chairman and CEO Todd Dollinger
Librae Holdings will purchase 103.6 million new ordinary shares in the capital of Trendlines, representing about 14.55% of the enlarged share capital of Trendlines following the placement. Librae Holdings will purchase the shares at a price of SGD 0.105 per share and for total consideration of SGD 10.88 million ($8 million at the exchange rate of $1.00 = SGD 1.360).